These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 19463303
1. Bifurcation disease: what do we know, what should we do? Latib A, Colombo A. JACC Cardiovasc Interv; 2008 Jun; 1(3):218-26. PubMed ID: 19463303 [Abstract] [Full Text] [Related]
2. Is there a higher risk of stent thrombosis in bifurcation lesion or is it related to the technique? Iakovou I, Kadota K, Papamentzelopoulos S, Pavlides G, Mitsudo K. EuroIntervention; 2010 Dec; 6 Suppl J():J107-11. PubMed ID: 21930473 [Abstract] [Full Text] [Related]
3. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease. De Luca L, Altamura L, Corvo P, De Persio G, Ghini AS, Petrolini A, Aurigemma C, Tomai F. Catheter Cardiovasc Interv; 2011 May 01; 77(6):765-72. PubMed ID: 21413124 [Abstract] [Full Text] [Related]
4. Double bifurcation lesion treated with double Tryton Sidebranch Stent: first case report. Unzué L, García E, Almería C. Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):E477-81. PubMed ID: 23378273 [Abstract] [Full Text] [Related]
5. Provisional side branch stenting for the treatment of bifurcation lesions. Lefèvre T, Darremont O, Albiero R. EuroIntervention; 2010 Dec 01; 6 Suppl J():J65-71. PubMed ID: 21930493 [No Abstract] [Full Text] [Related]
6. Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach. Tamura T, Kimura T, Morimoto T, Nakagawa Y, Furukawa Y, Kadota K, Tatami R, Kawai K, Sone T, Miyazaki S, Mitsudo K, j-Cypher Registry Investigators. EuroIntervention; 2011 Sep 01; 7(5):588-96. PubMed ID: 21930463 [Abstract] [Full Text] [Related]
7. Provisional side-branch stenting in distal left main lesions: one-size-may-not-fit-all. Belardi JA. Catheter Cardiovasc Interv; 2011 May 01; 77(6):773-4. PubMed ID: 21520379 [No Abstract] [Full Text] [Related]
8. Atheroma and coronary bifurcations: before and after stenting. Yazdani SK, Nakano M, Otsuka F, Kolodgie FD, Virmani R. EuroIntervention; 2010 Dec 01; 6 Suppl J():J24-30. PubMed ID: 21930487 [Abstract] [Full Text] [Related]
9. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent. Waksman R, Pakala R. EuroIntervention; 2009 Dec 15; 5 Suppl F():F36-42. PubMed ID: 22100674 [Abstract] [Full Text] [Related]
10. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Bonello L, De Labriolle A, Lemesle G, Roy P, Steinberg DH, Pichard AD, Waksman R. Arch Cardiovasc Dis; 2009 Feb 15; 102(2):143-51. PubMed ID: 19303582 [Abstract] [Full Text] [Related]
11. 3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique. Chue CD, Routledge HC, Ludman PF, Townend JN, Epstein AC, Buller NP, Doshi SN. Catheter Cardiovasc Interv; 2010 Mar 01; 75(4):605-13. PubMed ID: 20066725 [Abstract] [Full Text] [Related]
12. Stent thrombosis--risk assessment and prevention. Motovska Z, Knot J, Widimsky P. Cardiovasc Ther; 2010 Oct 01; 28(5):e92-100. PubMed ID: 20553282 [Abstract] [Full Text] [Related]
13. The STENTYS® self-apposing stent in bifurcation lesions. Ramcharitar S, Verheye S. EuroIntervention; 2010 Dec 01; 6 Suppl J():J151-4. PubMed ID: 21930482 [No Abstract] [Full Text] [Related]
14. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results. Kervinen K, Niemelä M, Romppanen H, Erglis A, Kumsars I, Maeng M, Holm NR, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galløe A, Narbute I, Sondore D, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Helqvist S, Vikman S, Wiseth R, Aarøe J, Jokelainen J, Thuesen L, Nordic PCI Study Group. JACC Cardiovasc Interv; 2013 Nov 01; 6(11):1160-5. PubMed ID: 24262616 [Abstract] [Full Text] [Related]
15. Left main stenting: is it a different animal? Park SJ, Park DW. EuroIntervention; 2010 Dec 01; 6 Suppl J():J112-7. PubMed ID: 21930474 [Abstract] [Full Text] [Related]
16. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. Brodie BR, Stuckey T, Downey W, Humphrey A, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Smith H, Edmunds J, Varanasi J, Simonton CA, STENT (Strategic Transcatheter Evaluation of New Therapies) Group. JACC Cardiovasc Interv; 2008 Aug 01; 1(4):405-14. PubMed ID: 19463338 [Abstract] [Full Text] [Related]
17. Is there a need for dedicated bifurcation devices? Lefèvre T, Chevalier B, Louvard Y. EuroIntervention; 2010 Dec 01; 6 Suppl J():J123-9. PubMed ID: 21930476 [No Abstract] [Full Text] [Related]
19. Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stents. Galassi AR, Tomasello SD, Capodanno D, Barrano G, Ussia GP, Tamburino C. JACC Cardiovasc Interv; 2009 Mar 26; 2(3):185-94. PubMed ID: 19463424 [Abstract] [Full Text] [Related]
20. Stent expansion as a mechanical parameter to predict late stent patency: back to the basics. Honda Y, Fitzgerald PJ. JACC Cardiovasc Interv; 2009 Dec 26; 2(12):1276-8. PubMed ID: 20129556 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]